LegoChem Biosciences Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 111
Employees
  • Stock Symbol
  • 141080
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $40.30
  • (As of Tuesday Closing)

LegoChem Biosciences General Information

Description

LegoChem Biosciences Inc develops new drugs through research. The Company provides business research services, manufacturing and sale of compounds, and drug evaluation.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
KRX
Primary Office
  • 8-26, Munpyeongseo-ro (Munpyeong-dong)
  • Daedeok-gu
  • Daejeon, 306-220
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LegoChem Biosciences Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$40.30 $39.16 $37.64 - $68.55 $944M 24.1M 219K -$1.40

LegoChem Biosciences Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,098,168 1,454,933 411,227 476,928
Revenue 36,748 41,834 49,311 22,964
EBITDA (31,876) (5,819) 13,250 (21,787)
Net Income (32,445) (5,917) 11,651 (23,447)
Total Assets 96,269 124,585 122,137 108,813
Total Debt 7,058 3,655 1,886 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

LegoChem Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore LegoChem Biosciences‘s full profile, request access.

Request a free trial

LegoChem Biosciences Patents

LegoChem Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019266406-A1 Compositions and methods related to anti-cd19 antibody drug conjugates Pending 09-May-2018 00000000000
EP-3790591-A2 Compositions and methods related to anti-cd19 antibody drug conjugates Pending 09-May-2018 00000000000
CA-3099680-A1 Compositions and methods related to anti-cd19 antibody drug conjugates Pending 09-May-2018 00000000000
US-20200095317-A1 Compositions and methods related to anti-cd19 antibody drug conjugates Pending 09-May-2018 00000000000
JP-2021523232-A Compositions and methods related to anti-cd19 antibody drug conjugates Pending 09-May-2018 C07K16/2803

LegoChem Biosciences Executive Team (7)

Name Title Board Seat Contact Info
Yong-Zu Kim Ph.D Co-Founder & Chief Executive Officer
Sejin Park Chief Financial Officer & Senior Vice President
Young-Lag Cho Ph.D Co-Founder & Chief Development Officer
YongSoo Yoon Director, Marketing
Jeiwook Chae Ph.D Chief Business Development Officer
You’re viewing 5 of 7 executive team members. Get the full list »

LegoChem Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LegoChem Biosciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore LegoChem Biosciences‘s full profile, request access.

Request a free trial

LegoChem Biosciences Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 01-Feb-2020 000000000 Other Healthcare Technology Systems
0000 000000000000 07-Jul-2016 000000000000000000 Drug Discovery 00000 0000
Khanmed 21-Dec-2015 Merger/Acquisition 000.00 Surgical Devices
To view LegoChem Biosciences’s complete investments and acquisitions history, request access »

LegoChem Biosciences Subsidiaries (1)

Company Name Industry Location Founded
0000000 Surgical Devices Seoul, South Korea 0000
To view LegoChem Biosciences’s complete subsidiaries history, request access »

LegoChem Biosciences Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000000000 07-Jul-2016 000000000000000000 Completed
  • 00000000 000000000
To view LegoChem Biosciences’s complete exits history, request access »